Back To Top
HERALD INTERVIEW
[Herald Interview] Arvelle was founded to in-license cenobamate: CEO
[Herald Interview] Arvelle was founded to in-license cenobamate: CEO
IndustryAug 6, 2020
Arvelle Therapeutics, founded in 2019, is a Switzerland-based biopharmaceutical company that focuses on innovative central nervous system drugs. The company’s noticeable idiosyncrasy? It has only on...